"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about LITHIUM
• Ask Community about LITHIUM
• LITHIUM Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

LITHIUM Safety Questions, LITHIUM Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LITHIUM. Our extensive database of LITHIUM adverse events and LITHIUM warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LITHIUM

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

LITHIUM Safety Reports

Total LITHIUM reports: 320.
LITHIUM FDA safety alerts: 2001 2004 .
Reported deaths: 34    Reported hospitalizations: 204.
Take LITHIUM Side Effects Survey or Share Your LITHIUM Story. LITHIUM Usage.

Showing 1-75 of 320 Next >

Consumer or non-health professional from reported LITHIUM problem on Mar 13, 2007. Female patient, 60 years of age, was diagnosed with bipolar disorder, nephrogenic diabetes insipidus and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus non-insulin-dependent, hypercalcaemia, hyperparathyroidism, hyperplasia, nephrogenic diabetes insipidus, polydipsia, polyuria. LITHIUM dosage: unknown. During the same period patient was treated with CHLORTHALIDONE. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Mar 12, 2007. Male patient, 63 years of age, weighting 260.1 lb, was diagnosed with bipolar disorder, asthma and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia, hyperparathyroidism, renal failure chronic. LITHIUM dosage: 450 MG DAILY. During the same period patient was treated with VALSARTAN, BUPROPION, IMIPRAMINE, ALBUTEROL. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on Mar 21, 2007. Male patient, 70 years of age, weighting 167.0 lb, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: chest pain, headache, paraesthesia. LITHIUM dosage: PO 2-300MG CAPS ONCE EVERY EVENING; ON 600 MG EVERY EVENING FOR 4-5 YEARS. During the same period patient was treated with SIMVASTATIN, CENTRUM SILVER, ASPIRIN. Patient recovered.

LITHIUM problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Female patient, 67 years of age, weighting 542.3 lb, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: confusional state, mental status changes, tremor. LITHIUM dosage: 300MG DAILY ORALLY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Nov 23, 2004. Male patient, 51 years of age, weighting 180.0 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: tardive dyskinesia. LITHIUM dosage: unknown. During the same period patient was treated with ZOLOFT, KLINOPIN, LAMICTAL, RESTORIL, ZYPREXA, RISPERDAL, SEROQUEL. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from INDIA on Mar 13, 2007. Male patient, 28 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: neurological symptom, neurotoxicity. LITHIUM dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on Mar 29, 2007. Female patient, 57 years of age, weighting 195.0 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: aphasia, confusional state, coordination abnormal, hallucination, visual, therapeutic agent toxicity, urinary incontinence. LITHIUM dosage: 300 MG TID PO. During the same period patient was treated with TRAMADOL, PAROXETINE, NAPROXEN. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Physician from SPAIN on Mar 14, 2007. Male patient, weighting 14.99 lb, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: abnormal labour, amniocentesis abnormal, caesarean section, ebstein's anomaly, neonatal disorder. LITHIUM dosage: unknown. During the same period patient was treated with CLONAZEPAM. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LITHIUM problem on Apr 05, 2007. Female patient, 32 years of age, weighting 135.4 lb, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, polyuria, tremor, urine electrolytes decreased, vomiting, weight increased. LITHIUM dosage: 300MG Q12H - 900 MG TID (PO). Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 03, 2007. Female patient, 24 years of age, was diagnosed with bipolar disorder, contraception and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: alopecia, hepatic function abnormal, hypomania, menometrorrhagia. LITHIUM dosage: unknown. During the same period patient was treated with VENLAFAXINE, CARBAMAZEPINE, DIVALPROEX, LAMOTRIGINE, ORAL CONTRACEPTIVES. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LITHIUM problem on Apr 09, 2007. Female patient, 18 years of age, weighting 114.6 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hepatic failure, thyroid disorder. LITHIUM dosage: 1,800 MG/DAY 3 TIMES A DAY. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Female patient, 50 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: mania. LITHIUM dosage: 300MG THREE TIMES PER DAY. During the same period patient was treated with PLAVIX, ASPIRIN, LEVOTHROID, XANAX, EXELON, MEVACOR, TOPAMAX, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE. Patient recovered.

Consumer or non-health professional from FRANCE reported LITHIUM problem on Apr 05, 2007. Female patient, 24 years of age, was diagnosed with depression, oral contraception and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypomania, menometrorrhagia. LITHIUM dosage: unknown. During the same period patient was treated with ETHINYL ESTRADIOL, GESTODENE, VENLAFAXINE. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 10, 2007. Female patient, 48 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hyperthyroidism, thyroiditis. LITHIUM dosage: unknown. Patient recovered.

Consumer or non-health professional from JAPAN reported LITHIUM problem on Mar 27, 2007. Male patient, 55 years of age, was diagnosed with schizophrenia and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: optic nerve disorder, papilloedema, visual acuity reduced. LITHIUM dosage: 600 MG, PER DAY; UNK. During the same period patient was treated with VALPROIC ACID, NITRAZEPAM, HALOPERIDOL, METHOTRIMEPRAZINE. Patient recovered.

LITHIUM problem was reported by a Physician from UNITED STATES on Mar 29, 2007. Male patient, 19 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. LITHIUM dosage: 600 MG; BID; PO. During the same period patient was treated with ARIPIPRAZOLE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Mar 15, 2006. Female patient, 21 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: nausea, nightmare, tremor. LITHIUM dosage: unknown. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2006. Female patient, 77 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: confusional state. LITHIUM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Apr 06, 2006. Female patient, 62 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. LITHIUM dosage: unknown. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2006. Female patient was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: adverse event. LITHIUM dosage: 300MG THREE TIMES PER DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on June 13, 2006. Male patient, 42 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: eating disorder, insomnia, sleep walking. LITHIUM dosage: unknown. During the same period patient was treated with NEURONTIN, LUVOX, KLONOPIN, ZOLOFT. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Female patient, 44 years of age, was diagnosed with bipolar disorder, hypertension and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: mania, renal failure chronic. LITHIUM dosage: unknown. During the same period patient was treated with LAMICTAL, SEROQUEL, KLONOPIN, LOTREL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Mar 13, 2006. Male patient, 51 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: dissociation, dizziness, feeling abnormal, stomach discomfort. LITHIUM dosage: 450MG TWICE PER DAY. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Female patient, 61 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: asthenia, bladder disorder, pain, pollakiuria, renal disorder. LITHIUM dosage: unknown. During the same period patient was treated with ESKALITH CR, SYNTHROID, PREMARIN, XANAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Apr 17, 2006. Female patient, 65 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: tremor. LITHIUM dosage: 900MG PER DAY. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 12, 2007. Female patient, 60 years of age, was diagnosed with mania, hypertension and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, dyskinesia, fall, gait disturbance, muscle rigidity, renal impairment, therapeutic agent toxicity. LITHIUM dosage: 900 - 1200 MG/DAY. During the same period patient was treated with LITHIUM CARBONATE, LITHIUM CARBONATE, VALSARTAN, VALPROATE, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LITHIUM problem on Apr 12, 2007. Male patient, 50 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: folliculitis, hypertrichosis, rash papular, rash pruritic, renal failure, sebaceous hyperplasia, squamous cell carcinoma. LITHIUM dosage: unknown. During the same period patient was treated with AZATHIOPRINE, CARBAMAZEPINE, CYCLOSPORINE. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Apr 11, 2007. Female patient, 60 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: mania, therapeutic agent toxicity. LITHIUM dosage: DAILY DOSE:600MG. During the same period patient was treated with VALSARTAN, VALPROATE, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LITHIUM problem on Apr 05, 2007. Female patient, 61 years of age, weighting 82.00 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: tremor. LITHIUM dosage: 2.5, 3.5 AND 3.6ML/DAY. During the same period patient was treated with CLONIDINE, PREDNISONE, PROGRAF, RAPAMUNE. Patient recovered.

LITHIUM problem was reported by a Physician from UNITED STATES on Apr 05, 2007. Female patient, 61 years of age, weighting 82.00 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: tremor. LITHIUM dosage: 2.5, 3.5 AND 3.6 ML/DAY; ORALLY. During the same period patient was treated with CLONIDINE, PREDNISONE, PROGRAF, RAPAMUNE. Patient recovered.

Health Professional from UNITED STATES reported LITHIUM problem on Apr 25, 2007. Female patient was diagnosed with bipolar disorder, schizoaffective disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: condition aggravated, psychiatric symptom. LITHIUM dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on Apr 26, 2007. Female patient, weighting 198.4 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: haemodialysis, renal failure chronic, renal transplant, therapeutic agent toxicity. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Apr 27, 2007. Female patient, 68 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypertension, palpitations, thrombosis. LITHIUM dosage: 450MG TWICE PER DAY. During the same period patient was treated with ASPIRIN. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 25, 2007. Female patient, 52 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, renal failure acute, therapeutic agent toxicity. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LITHIUM problem on Apr 25, 2007. Female patient, 44 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, erythema multiforme, renal failure acute, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, PERPHENAZINE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 25, 2007. Male patient, 57 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, renal failure acute, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE, PAROXETINE, VALPROIC ACID, PROPRANOLOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LITHIUM problem on Apr 25, 2007. Male patient, 55 years of age, was diagnosed with mania and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: headache, optic atrophy, papillitis, papilloedema, pupillary reflex impaired, vision blurred, visual acuity reduced. LITHIUM dosage: unknown. During the same period patient was treated with VALPROIC ACID, NITRAZEPAM, HALOPERIDOL, LEVOPROMAZINE, PIPERIDINE. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from GERMANY on Apr 24, 2007. Female patient, 38 years of age, was diagnosed with prophylaxis and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased, hepatic steatosis, hyperlipidaemia, impaired fasting glucose, lipase increased. LITHIUM dosage: unknown. During the same period patient was treated with RISPERIDONE, LORAZEPAM, PIPAMPERONE, ZOPICLON. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on May 04, 2007. Female patient, 50 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: encephalopathy, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with REVLIMID, TYLENOL, ACYCLOVIR, CEFEPIME, FOLIC ACID, HALDOL, SYNTHROID, ATIVAN. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Male patient, 57 years of age, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar syndrome, overdose, therapeutic agent toxicity. LITHIUM dosage: DAILY DOSE:600MG. During the same period patient was treated with CANNABIS, ALCOHOL, QUETIAPINE FUMARATE, PAROXETINE, VALPROIC ACID, PROPRANOLOL. Patient recovered.

Consumer or non-health professional from reported LITHIUM problem on May 02, 2007. Female patient, 64 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, bundle branch block right, cerebral atrophy, cerebrovascular accident, electrocardiogram t wave inversion, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with SERTRALINE, HALOPERIDOL. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Female patient, 44 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar syndrome, erythema multiforme, therapeutic agent toxicity. LITHIUM dosage: DAILY DOSE:1500MG. During the same period patient was treated with CARBAMAZEPINE, PERPHENAZINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Apr 26, 2007. Female patient, 52 years of age, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar syndrome, therapeutic agent toxicity. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2007. Female patient, 39 years of age, weighting 195.0 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cardiac flutter, confusional state, constipation, coordination abnormal, diarrhoea, dysarthria, dyskinesia, fall, fatigue. LITHIUM dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on May 07, 2007. Male patient, 51 years of age, weighting 271.4 lb, was diagnosed with affective disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, diarrhoea, hyponatraemia, nausea, oral intake reduced, vomiting. LITHIUM dosage: 600 MG PO BID WITH FOOD. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on May 09, 2007. Female patient, 32 years of age, was diagnosed with intentional overdose and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: intentional overdose, suicide attempt, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with CLORAZEPATE, CLOMIPRAMINE, LORAZEPAM, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LITHIUM problem on May 09, 2007. Male patient, 64 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: bradycardia, hypotension, presyncope, sinus arrest, sinus arrhythmia. LITHIUM dosage: 1200 MG QD. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on May 10, 2007. Male patient, 59 years of age, was diagnosed with schizophrenia and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dialysis, mental status changes, rebound effect, therapeutic agent toxicity. LITHIUM dosage: 150MG DAILY PO. During the same period patient was treated with COMBIVENT, XOPENEX, MOMETASONE FUROATE, ASPIRIN, KLONOPIN, METOPROLOL TARTRATE, TRAZODONE, RISPERDAL. Patient was hospitalized. Patient died on 01/02/2007.

Consumer or non-health professional from UNITED KINGDOM reported LITHIUM problem on May 14, 2007. Male patient, 63 years of age, was diagnosed with bipolar disorder, convulsion, left ventricular failure and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: nephrogenic diabetes insipidus, renal failure acute. LITHIUM dosage: unknown. During the same period patient was treated with ARIPIPRAZOLE, EPILIM, FRUSEMIDE, OMEPRAZOLE, POTASSIUM SULPHATE, RAMIPRIL. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on May 15, 2007. Male patient, child 11 years of age, was diagnosed with post-traumatic stress disorder, tremor and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: anticholinergic syndrome, cogwheel rigidity, confusional state, dry mouth, dry skin, fatigue, hypokinesia, malaise, oral candidiasis. LITHIUM dosage: unknown. During the same period patient was treated with CHLORPROMAZINE, BENZTROPINE, RISPERIDONE, VALPROIC ACID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported LITHIUM problem on May 02, 2007. Female patient, 38 years of age, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: glucose tolerance impaired, hypercholesterolaemia, hypertriglyceridaemia, lipase increased. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Physician from TAIWAN, PROVINCE OF CHINA on May 02, 2007. Female patient, 60 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: azotaemia, coordination abnormal, fall, gait disturbance, hypokinesia, mania, muscle rigidity. LITHIUM dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, VALPROATE, CLONAZEPAM, VALSARTAN, RISPERIDONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CANADA reported LITHIUM problem on May 02, 2007. Male patient, 65 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: anion gap decreased, blood bicarbonate increased, blood calcium increased, depressed level of consciousness, dysarthria, haemodialysis, heart rate increased, osmolar gap abnormal, overdose. LITHIUM dosage: 300 MG. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Physician from UNITED STATES on May 03, 2007. Male patient, 17 years of age, was diagnosed with schizophrenia, catatonic type and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, coordination abnormal, delusion, disorientation, extrapyramidal disorder, inappropriate affect. LITHIUM dosage: 900 MG; QD; PO. During the same period patient was treated with ZIPRASIDONE. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LITHIUM problem on May 15, 2007. Female patient, 71 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: motor neurone disease. LITHIUM dosage: unknown. Patient died on 01/01/2007.

LITHIUM problem was reported by a Consumer or non-health professional from on May 22, 2007. Female patient, 43 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, bradycardia, hypochloraemia, hypokalaemia, hypotension, hypothermia, metabolic alkalosis, sinoatrial block, therapeutic agent toxicity. LITHIUM dosage: 600 MG BID. During the same period patient was treated with NAPROXEN, MIRTAZAPINE, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LITHIUM problem on May 11, 2007. Male patient, 19 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome, no therapeutic response. LITHIUM dosage: unknown. During the same period patient was treated with ARIPIPRAZOLE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on May 24, 2007. Male patient, 60 years of age, weighting 184.1 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypernatraemia, nephrogenic diabetes insipidus. LITHIUM dosage: 150 MG PO Q6 HRS (DURATION: } 1YEAR PTA). Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SPAIN reported LITHIUM problem on May 16, 2007. Female patient, 32 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: haemodialysis, intentional overdose, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with CLORAZEPATE MONOPOTASSIUM, CLOMIPRAMINE, LORAZEPAM, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on May 31, 2007. Male patient, 48 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, confusional state, convulsion, tremor. LITHIUM dosage: 450MG HS PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on May 29, 2007. Female patient, 27 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, haemodialysis, nausea, therapeutic agent toxicity. LITHIUM dosage: unknown. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on May 31, 2007. Male patient, 65 years of age, was diagnosed with bipolar disorder, hypertension and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: anion gap abnormal, depressed level of consciousness, osmolar gap abnormal, overdose. LITHIUM dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on May 29, 2007. Female patient, 43 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate increased, blood creatinine increased, bradycardia, electrocardiogram qrs complex shortened, electrocardiogram t wave amplitude decreased, haemodialysis, hypochloraemia, hypokalaemia. LITHIUM dosage: unknown. During the same period patient was treated with NAPROXEN, AMITRIPTYLINE, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from TURKEY on May 29, 2007. Female patient, 54 years of age, was diagnosed with mania and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, extrapyramidal disorder, hyperthyroidism, neuroleptic malignant syndrome, pneumonia, thalassaemia beta. LITHIUM dosage: DAILY DOSE:1200MG. During the same period patient was treated with RISPERIDONE, BIPERIDEN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on June 11, 2007. Female patient, 55 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: agitation, muscle twitching, neuromyopathy, therapeutic agent toxicity, tremor. LITHIUM dosage: 600MG DAILY PO. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on June 14, 2007. Male patient, weighting 180.0 lb, was diagnosed with irritability and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: balance disorder, communication disorder, hypotonia, ill-defined disorder, myoclonus, posture abnormal, spinal disorder, tremor. LITHIUM dosage: 300 MG BID TO TID TO BID PO. During the same period patient was treated with LITHIUM CARBONATE, FAZACLO ODT, INVEGA, LISINOPRIL, ATROPINE, RISPERDAL, DEPAKOTE ER. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on June 19, 2007. Male patient, weighting 168.0 lb, was diagnosed with bipolar disorder, schizophrenia and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine increased, hepatic steatosis, hypernatraemia, lethargy, mental status changes, nephrogenic diabetes insipidus. LITHIUM dosage: 300MG BID PO. During the same period patient was treated with LITHIUM CARBONATE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on June 19, 2007. Male patient, 59 years of age, weighting 191.8 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: headache, nausea, tremor. LITHIUM dosage: 600MG/900MG QAM/QHS PO. Patient was hospitalized. Patient recovered.

Physician from POLAND reported LITHIUM problem on June 11, 2007. Female patient, 71 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: asthenia, bradycardia, hypotonia, mental disorder, therapeutic agent toxicity. LITHIUM dosage: 1000 MG,. During the same period patient was treated with DIGOXIN, CARBAMAZEPINE, FUROSEMIDE. Patient recovered.

LITHIUM problem was reported by a Physician from SPAIN on June 08, 2007. Male patient, 29 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, addison's disease, adrenocortical insufficiency acute, anorexia, asthenia, autoimmune disorder, condition aggravated, dehydration, dizziness. LITHIUM dosage: unknown. During the same period patient was treated with FLUDROCORTISONE ACETATE, PERICYAZINE, LORAZEPAM, HYDROCORTISONE, HALOPERIDOL, PREDNISONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Aug 28, 2006. Female patient, 57 years of age, weighting 148.0 lb, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. LITHIUM dosage: 300 MG. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 19, 2007. Female patient, 31 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, oligomenorrhoea, suicide attempt. LITHIUM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on June 21, 2007. Male patient, weighting 160.1 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: angioedema, urticaria. LITHIUM dosage: unknown. During the same period patient was treated with LAMICTAL, ABILIFY. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from GERMANY on June 13, 2007. Female patient, 33 years of age, weighting 185.2 lb, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: glucose tolerance impaired, hepatic steatosis, hypercholesterolaemia, hyperlipidaemia, hypertriglyceridaemia, impaired fasting glucose, lipase increased, mixed hyperlipidaemia. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on July 11, 2006. Male patient, weighting 255.7 lb, was diagnosed with bipolar disorder, incontinence and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: diabetes insipidus, incontinence, micturition urgency, nocturia. LITHIUM dosage: 300MG/600MG DAILY PO. During the same period patient was treated with BETHANECHOL, TRAZODONE, PROZAC, BUPROPION, NEURONTIN, VALPROIC ACID, TEMAZEPAM, CLONAZEPAM. Patient recovered.

Showing 1-75 of 320 Next >

Ask Our Patient Community about LITHIUM
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept)